Global Bone Marrow Transplantation

Bone Marrow Transplantation Comprehensive Study by Type (Allogeneic Bone Marrow Transplant, Autologous Bone Marrow Transplant), Indication (Leukemia, Lymphoma, Myeloma, Myelodysplasia, Myeloproliferative Neoplasms, Aplastic Anemia, Sickle Cell Anemia, Others), End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2030

Bone Marrow Transplantation Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Bone Marrow Transplantation
Increasing R&D in stem cell therapy and rising patient survival rates after bone marrow transplantation providing lucrative opportunities to the market players. Bone marrow transplantation refers to the procedure performed to replace bone marrow that has been damaged or destroyed by various reasons such as disease, chemotherapy, or infection. This procedure involves transplanting blood stem cells that produce new blood cells and promote the growth of new marrow. Bone marrow transplantation is a treatment for an increasingly wide range of hematologic, neoplastic, and immunologic diseases.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Ongoing awareness of developments in medical technologies is integral to understanding and utilizing the best options available. Development in the field of Bone Marrow Transplantation increases the opportunities for key players. Both mechanical and biological (stem cell) organ replacement therapies may change the profile of the transplant. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Bone Marrow Transplantation market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

AllCells LLC. (United States), FUJIFILM Cellular Dynamics, Inc. (United States), Gamida-Cell Ltd. (Israel), Hemacare Corporation (United States), Lonza Group AG (Switzerland), Merck Millipore Corporation (United States), Mesoblast Ltd. (Australia), PromoCell GmbH (Germany) and STEMCELL Technologies Inc (Canada) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Bone Marrow Transplantation market by Type (Allogeneic Bone Marrow Transplant and Autologous Bone Marrow Transplant) and Region.



On the basis of geography, the market of Bone Marrow Transplantation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Indication, the sub-segment i.e. Leukemia will boost the Bone Marrow Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Bone Marrow Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement and Innovation In Medical Sector and Increasing Adoption of Half-matched Transplant Option

Market Growth Drivers:
Increasing Prevalence of Blood Cancer and other Blood-related Diseases and Rising Awareness Coupled with a Rise in Promotional Campaigns Run by Healthcare Practitioners

Challenges:
Lack of Awareness in Some Regions

Restraints:
High Cost of Transplantation and Lack of Reimbursement Policies

Opportunities:
Increasing R&D in Stem Cell Therapy and Rising Patient Survival Rates after Bone Marrow Transplantation

Market Leaders and their expansionary development strategies
On July 5, 2023, Vericel Corporation was Acquired by Magenta Therapeutics: This acquisition strengthens Magenta's portfolio in cellular therapies for blood cancers, incorporating Vericel's bone marrow processing and cryopreservation expertise.
On November 16, 2023, Miltenyi Biotec launched CliniMACS Prodigy® for Automated CD34+ Cell Selection. This innovative platform streamlines the isolation of hematopoietic stem cells for bone marrow transplantation, improving efficiency and potentially boosting clinical outcomes.


Key Target Audience
Pharmaceutical Companies, Research and Development (R&D) Companies, Independent Research Laboratories, Market Research and Consulting Service Providers, Medical Research Laboratories, Academic Medical Institutes and Universities and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
By Indication
  • Leukemia
  • Lymphoma
  • Myeloma
  • Myelodysplasia
  • Myeloproliferative Neoplasms
  • Aplastic Anemia
  • Sickle Cell Anemia
  • Others

By End User
  • Hospitals
  • Multi-Specialty Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Blood Cancer and other Blood-related Diseases
      • 3.2.2. Rising Awareness Coupled with a Rise in Promotional Campaigns Run by Healthcare Practitioners
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Some Regions
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement and Innovation In Medical Sector
      • 3.4.2. Increasing Adoption of Half-matched Transplant Option
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bone Marrow Transplantation, by Type, Indication, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Bone Marrow Transplantation (Value)
      • 5.2.1. Global Bone Marrow Transplantation by: Type (Value)
        • 5.2.1.1. Allogeneic Bone Marrow Transplant
        • 5.2.1.2. Autologous Bone Marrow Transplant
      • 5.2.2. Global Bone Marrow Transplantation by: Indication (Value)
        • 5.2.2.1. Leukemia
        • 5.2.2.2. Lymphoma
        • 5.2.2.3. Myeloma
        • 5.2.2.4. Myelodysplasia
        • 5.2.2.5. Myeloproliferative Neoplasms
        • 5.2.2.6. Aplastic Anemia
        • 5.2.2.7. Sickle Cell Anemia
        • 5.2.2.8. Others
      • 5.2.3. Global Bone Marrow Transplantation by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Multi-Specialty Clinics
        • 5.2.3.3. Ambulatory Surgical Centers
      • 5.2.4. Global Bone Marrow Transplantation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Bone Marrow Transplantation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AllCells LLC. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. FUJIFILM Cellular Dynamics, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Gamida-Cell Ltd. (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hemacare Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lonza Group AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck Millipore Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mesoblast Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PromoCell GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. STEMCELL Technologies Inc (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Bone Marrow Transplantation Sale, by Type, Indication, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Bone Marrow Transplantation (Value)
      • 7.2.1. Global Bone Marrow Transplantation by: Type (Value)
        • 7.2.1.1. Allogeneic Bone Marrow Transplant
        • 7.2.1.2. Autologous Bone Marrow Transplant
      • 7.2.2. Global Bone Marrow Transplantation by: Indication (Value)
        • 7.2.2.1. Leukemia
        • 7.2.2.2. Lymphoma
        • 7.2.2.3. Myeloma
        • 7.2.2.4. Myelodysplasia
        • 7.2.2.5. Myeloproliferative Neoplasms
        • 7.2.2.6. Aplastic Anemia
        • 7.2.2.7. Sickle Cell Anemia
        • 7.2.2.8. Others
      • 7.2.3. Global Bone Marrow Transplantation by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Multi-Specialty Clinics
        • 7.2.3.3. Ambulatory Surgical Centers
      • 7.2.4. Global Bone Marrow Transplantation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bone Marrow Transplantation: by Type(USD Million)
  • Table 2. Bone Marrow Transplantation Allogeneic Bone Marrow Transplant , by Region USD Million (2018-2023)
  • Table 3. Bone Marrow Transplantation Autologous Bone Marrow Transplant , by Region USD Million (2018-2023)
  • Table 4. Bone Marrow Transplantation: by Indication(USD Million)
  • Table 5. Bone Marrow Transplantation Leukemia , by Region USD Million (2018-2023)
  • Table 6. Bone Marrow Transplantation Lymphoma , by Region USD Million (2018-2023)
  • Table 7. Bone Marrow Transplantation Myeloma , by Region USD Million (2018-2023)
  • Table 8. Bone Marrow Transplantation Myelodysplasia , by Region USD Million (2018-2023)
  • Table 9. Bone Marrow Transplantation Myeloproliferative Neoplasms , by Region USD Million (2018-2023)
  • Table 10. Bone Marrow Transplantation Aplastic Anemia , by Region USD Million (2018-2023)
  • Table 11. Bone Marrow Transplantation Sickle Cell Anemia , by Region USD Million (2018-2023)
  • Table 12. Bone Marrow Transplantation Others , by Region USD Million (2018-2023)
  • Table 13. Bone Marrow Transplantation: by End User(USD Million)
  • Table 14. Bone Marrow Transplantation Hospitals , by Region USD Million (2018-2023)
  • Table 15. Bone Marrow Transplantation Multi-Specialty Clinics , by Region USD Million (2018-2023)
  • Table 16. Bone Marrow Transplantation Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 17. South America Bone Marrow Transplantation, by Country USD Million (2018-2023)
  • Table 18. South America Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 19. South America Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 20. South America Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 21. Brazil Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 22. Brazil Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 23. Brazil Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 24. Argentina Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 25. Argentina Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 26. Argentina Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 27. Rest of South America Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 29. Rest of South America Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 30. Asia Pacific Bone Marrow Transplantation, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 33. Asia Pacific Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 34. China Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 35. China Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 36. China Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 37. Japan Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 38. Japan Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 39. Japan Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 40. India Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 41. India Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 42. India Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 43. South Korea Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 44. South Korea Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 45. South Korea Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 46. Taiwan Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 47. Taiwan Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 48. Taiwan Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 49. Australia Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 50. Australia Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 51. Australia Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 55. Europe Bone Marrow Transplantation, by Country USD Million (2018-2023)
  • Table 56. Europe Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 57. Europe Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 58. Europe Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 59. Germany Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 60. Germany Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 61. Germany Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 62. France Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 63. France Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 64. France Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 65. Italy Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 66. Italy Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 67. Italy Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 68. United Kingdom Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 70. United Kingdom Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 71. Netherlands Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 72. Netherlands Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 73. Netherlands Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 74. Rest of Europe Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 76. Rest of Europe Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 77. MEA Bone Marrow Transplantation, by Country USD Million (2018-2023)
  • Table 78. MEA Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 79. MEA Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 80. MEA Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 81. Middle East Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 82. Middle East Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 83. Middle East Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 84. Africa Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 85. Africa Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 86. Africa Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 87. North America Bone Marrow Transplantation, by Country USD Million (2018-2023)
  • Table 88. North America Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 89. North America Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 90. North America Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 91. United States Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 92. United States Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 93. United States Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 94. Canada Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 95. Canada Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 96. Canada Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 97. Mexico Bone Marrow Transplantation, by Type USD Million (2018-2023)
  • Table 98. Mexico Bone Marrow Transplantation, by Indication USD Million (2018-2023)
  • Table 99. Mexico Bone Marrow Transplantation, by End User USD Million (2018-2023)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Bone Marrow Transplantation: by Type(USD Million)
  • Table 110. Bone Marrow Transplantation Allogeneic Bone Marrow Transplant , by Region USD Million (2025-2030)
  • Table 111. Bone Marrow Transplantation Autologous Bone Marrow Transplant , by Region USD Million (2025-2030)
  • Table 112. Bone Marrow Transplantation: by Indication(USD Million)
  • Table 113. Bone Marrow Transplantation Leukemia , by Region USD Million (2025-2030)
  • Table 114. Bone Marrow Transplantation Lymphoma , by Region USD Million (2025-2030)
  • Table 115. Bone Marrow Transplantation Myeloma , by Region USD Million (2025-2030)
  • Table 116. Bone Marrow Transplantation Myelodysplasia , by Region USD Million (2025-2030)
  • Table 117. Bone Marrow Transplantation Myeloproliferative Neoplasms , by Region USD Million (2025-2030)
  • Table 118. Bone Marrow Transplantation Aplastic Anemia , by Region USD Million (2025-2030)
  • Table 119. Bone Marrow Transplantation Sickle Cell Anemia , by Region USD Million (2025-2030)
  • Table 120. Bone Marrow Transplantation Others , by Region USD Million (2025-2030)
  • Table 121. Bone Marrow Transplantation: by End User(USD Million)
  • Table 122. Bone Marrow Transplantation Hospitals , by Region USD Million (2025-2030)
  • Table 123. Bone Marrow Transplantation Multi-Specialty Clinics , by Region USD Million (2025-2030)
  • Table 124. Bone Marrow Transplantation Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 125. South America Bone Marrow Transplantation, by Country USD Million (2025-2030)
  • Table 126. South America Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 127. South America Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 128. South America Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 129. Brazil Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 130. Brazil Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 131. Brazil Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 132. Argentina Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 133. Argentina Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 134. Argentina Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 135. Rest of South America Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 136. Rest of South America Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 137. Rest of South America Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 138. Asia Pacific Bone Marrow Transplantation, by Country USD Million (2025-2030)
  • Table 139. Asia Pacific Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 140. Asia Pacific Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 141. Asia Pacific Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 142. China Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 143. China Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 144. China Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 145. Japan Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 146. Japan Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 147. Japan Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 148. India Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 149. India Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 150. India Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 151. South Korea Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 152. South Korea Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 153. South Korea Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 154. Taiwan Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 155. Taiwan Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 156. Taiwan Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 157. Australia Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 158. Australia Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 159. Australia Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 162. Rest of Asia-Pacific Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 163. Europe Bone Marrow Transplantation, by Country USD Million (2025-2030)
  • Table 164. Europe Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 165. Europe Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 166. Europe Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 167. Germany Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 168. Germany Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 169. Germany Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 170. France Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 171. France Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 172. France Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 173. Italy Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 174. Italy Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 175. Italy Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 176. United Kingdom Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 177. United Kingdom Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 178. United Kingdom Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 179. Netherlands Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 180. Netherlands Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 181. Netherlands Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 182. Rest of Europe Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 183. Rest of Europe Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 184. Rest of Europe Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 185. MEA Bone Marrow Transplantation, by Country USD Million (2025-2030)
  • Table 186. MEA Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 187. MEA Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 188. MEA Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 189. Middle East Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 190. Middle East Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 191. Middle East Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 192. Africa Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 193. Africa Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 194. Africa Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 195. North America Bone Marrow Transplantation, by Country USD Million (2025-2030)
  • Table 196. North America Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 197. North America Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 198. North America Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 199. United States Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 200. United States Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 201. United States Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 202. Canada Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 203. Canada Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 204. Canada Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 205. Mexico Bone Marrow Transplantation, by Type USD Million (2025-2030)
  • Table 206. Mexico Bone Marrow Transplantation, by Indication USD Million (2025-2030)
  • Table 207. Mexico Bone Marrow Transplantation, by End User USD Million (2025-2030)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bone Marrow Transplantation: by Type USD Million (2018-2023)
  • Figure 5. Global Bone Marrow Transplantation: by Indication USD Million (2018-2023)
  • Figure 6. Global Bone Marrow Transplantation: by End User USD Million (2018-2023)
  • Figure 7. South America Bone Marrow Transplantation Share (%), by Country
  • Figure 8. Asia Pacific Bone Marrow Transplantation Share (%), by Country
  • Figure 9. Europe Bone Marrow Transplantation Share (%), by Country
  • Figure 10. MEA Bone Marrow Transplantation Share (%), by Country
  • Figure 11. North America Bone Marrow Transplantation Share (%), by Country
  • Figure 12. Global Bone Marrow Transplantation share by Players 2023 (%)
  • Figure 13. Global Bone Marrow Transplantation share by Players (Top 3) 2023(%)
  • Figure 14. Global Bone Marrow Transplantation share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. AllCells LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 17. AllCells LLC. (United States) Revenue: by Geography 2023
  • Figure 18. FUJIFILM Cellular Dynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. FUJIFILM Cellular Dynamics, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Gamida-Cell Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 21. Gamida-Cell Ltd. (Israel) Revenue: by Geography 2023
  • Figure 22. Hemacare Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Hemacare Corporation (United States) Revenue: by Geography 2023
  • Figure 24. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. Lonza Group AG (Switzerland) Revenue: by Geography 2023
  • Figure 26. Merck Millipore Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck Millipore Corporation (United States) Revenue: by Geography 2023
  • Figure 28. Mesoblast Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 29. Mesoblast Ltd. (Australia) Revenue: by Geography 2023
  • Figure 30. PromoCell GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. PromoCell GmbH (Germany) Revenue: by Geography 2023
  • Figure 32. STEMCELL Technologies Inc (Canada) Revenue, Net Income and Gross profit
  • Figure 33. STEMCELL Technologies Inc (Canada) Revenue: by Geography 2023
  • Figure 34. Global Bone Marrow Transplantation: by Type USD Million (2025-2030)
  • Figure 35. Global Bone Marrow Transplantation: by Indication USD Million (2025-2030)
  • Figure 36. Global Bone Marrow Transplantation: by End User USD Million (2025-2030)
  • Figure 37. South America Bone Marrow Transplantation Share (%), by Country
  • Figure 38. Asia Pacific Bone Marrow Transplantation Share (%), by Country
  • Figure 39. Europe Bone Marrow Transplantation Share (%), by Country
  • Figure 40. MEA Bone Marrow Transplantation Share (%), by Country
  • Figure 41. North America Bone Marrow Transplantation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AllCells LLC. (United States)
  • FUJIFILM Cellular Dynamics, Inc. (United States)
  • Gamida-Cell Ltd. (Israel)
  • Hemacare Corporation (United States)
  • Lonza Group AG (Switzerland)
  • Merck Millipore Corporation (United States)
  • Mesoblast Ltd. (Australia)
  • PromoCell GmbH (Germany)
  • STEMCELL Technologies Inc (Canada)
Select User Access Type

Key Highlights of Report


Jan 2024 229 Pages 78 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bone Marrow Transplantation Quantitative research analysis
Global Bone Marrow Transplantation Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as AllCells LLC. (United States), FUJIFILM Cellular Dynamics, Inc. (United States), Gamida-Cell Ltd. (Israel), Hemacare Corporation (United States), Lonza Group AG (Switzerland), Merck Millipore Corporation (United States), Mesoblast Ltd. (Australia), PromoCell GmbH (Germany) and STEMCELL Technologies Inc (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology Advancement and Innovation In Medical Sector " is seen as one of major influencing trends for Bone Marrow Transplantation Market during projected period 2023-2030.
The Bone Marrow Transplantation market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Bone Marrow Transplantation Report?

Have a Query? Click Here

Other Related Reports

Anti-aging Services Comprehensive Study by Type (Face, Body), Form (Cream, Serum, Gel), Ingredient (Vitamin E, Vitamin C, Retinol, Aloe, Shea Butter, Alpha Hydroxy), Container (Jar, Bottle, Tube, Pu...
$ 3500
Paget's Disease Treatment Comprehensive Study by Route of Administration (Oral, Intravenous, Topical), Treatment (Actonel, Reclast, Zoledronic Acid, Fosamax, Miacalcin, Aredia, Calcitonin, Zometa, Ot...
$ 3750
Acute Lung Injury Comprehensive Study by Therapy (Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centres...
$ 3450
Telmisartan and Hydrochlorothiazide Drug Comprehensive Study by Type (80 mg/12.5 mg tablets, 40 mg/12.5 mg tablets, 80 mg/25 mg tablets), Application (Hypertension, Fluid Retention, Prevents Heart At...
$ 3750
Actinic Keratosis Therapeutics Comprehensive Study by Type (Combination Therapy, Photodynamic Therapy), Application (Hospitals & Oncology Centers, Dermatology Clinics, Ambulatory Surgical Centers), D...
$ 3650
Opthalmology Drugs Comprehensive Study by Type (Prescription Drugs, Over-the-Counter Drugs), Application (Maintenance and Servicing, User Acceptance and Adaptation), Indication (Dry Eye, Glaucoma, In...
$ 3750